Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
01 March 2022 - 10:25PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
________________
FORM 6-K
________________
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
February 28, 2022
________________
NOVO NORDISK A/S
(Exact name
of Registrant as specified in its charter)
Novo Allé
DK- 2880, Bagsvaerd
Denmark
(Address of principal executive offices)
________________
Indicate by check mark whether the registrant files or will file annual reports under
cover of Form 20-F or Form 40-F
Form 20-F [X] |
Form 40-F [ ] |
Indicate by check mark whether the registrant by furnishing the information contained
in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange
Act of 1934.
If “Yes” is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g-32(b):82-________
Election
of employee representatives to the Board of Directors of Novo Nordisk A/S
Bagsværd,
Denmark, 28 February 2022 – The employees in Novo Nordisk A/S have completed the election of employee representatives
to the Board of Directors of Novo Nordisk A/S.
The following were elected for the next four years:
| · | Elisabeth Dahl Christensen (newly elected) |
| · | Liselotte Hyveled (newly elected) |
| · | Mette Bøjer Jensen (re-elected) |
| · | Thomas Rantzau (re-elected) |
As substitutes for the employee-elected board members, the
following were elected:
The new employee-elected board members will join the
Board of Directors following the annual general meeting of Novo Nordisk A/S on 24 March 2022. At the same time the current board members
Anne Marie Kverneland, who did not run for election, and Stig Strøbæk, who was not re-elected, will resign.
About employee-elected board members
According to the Danish Companies Act, the employees
of Novo Nordisk A/S are entitled to be represented by half of the total shareholder-elected Board members. Employee-elected board members
serve for a statutory four-year term and have the same rights, duties and responsibilities as shareholder-elected board members.
Novo Nordisk is a leading
global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other
serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding
access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 47,800 people in 80 countries
and markets its products in around 170 countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen (Novo-B). Its ADRs are listed
on the New York Stock Exchange (NVO). For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn and YouTube.
Further information
Media: |
|
|
Mette Kruse Danielsen |
+45 3079 3883 |
mkd@novonordisk.com |
Michael Bachner (US) |
+1 609 664 7308 |
mzyb@novonordisk.com |
|
|
|
Investors: |
|
|
Daniel Muusmann Bohsen |
+45 3075 2175 |
dabo@novonordisk.com |
Ann Søndermølle Rendbæk |
+45 3075 2253 |
arnd@novonordisk.com |
David Heiberg Landsted |
+45 3077 6915 |
dhel@novonordisk.com |
Jacob Martin Wiborg Rode |
+45 3075 5956 |
jrde@novonordisk.com |
Mark Joseph Root (US) |
+1 848 213 3219 |
mjhr@novonordisk.com |
Novo Nordisk A/S
Investor Relations |
Novo Allé
2880 Bagsværd
Denmark |
Telephone:
+45 4444 8888 |
Internet:
www.novonordisk.com
CVR no:
24 25 67 90 |
|
|
Company announcement No 18 / 2022 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized.
Date: February 28, 2022 |
NOVO NORDISK A/S
Lars Fruergaard Jørgensen
Chief Executive Officer |
Novo Nordisk (PK) (USOTC:NONOF)
Historical Stock Chart
From Jun 2024 to Jul 2024
Novo Nordisk (PK) (USOTC:NONOF)
Historical Stock Chart
From Jul 2023 to Jul 2024